The Influence of CB2-Receptor Ligands on the Memory-Related Responses in Connection with Cholinergic Pathways in Mice in the Passive Avoidance Test
Open Access
Abstract
Background: Dysfunction of the cholinergic system is associated with the development of Alzheimer’s disease (AD). One of the new possible strategies for the pharmacological modulation of memory-related problems typical of AD, is connected with the endocannabinoid system (ECS) and the cannabinoid (CB: CB1 and CB2) receptors. Methods: The aim of the study was to determine the influence of the selective CB2 receptor ligands: agonist (JWH 133) and antagonist (AM 630) on different stages of memory and learning in mice, in the context of their interaction with cholinergic pathways. To assess and understand the memory-related effects in mice we used the passive avoidance (PA) test. Results: We revealed that co-administration of non-effective dose of JWH 133 (0.25 mg) or AM 630 (0.25 mg/kg) with the non-effective dose of cholinergic receptor agonist - nicotine (0.05 mg/kg) enhanced cognition in the PA test in mice; however, an acute injection of JWH 133 (0.25 mg/kg) or AM 630 (0.25 mg/kg) had no influence on memory enhancement induced by the effective dose of nicotine (0.1 mg/kg). Co-administration of JWH 133 (0.25 mg) or AM 630 (0.25 mg/kg) with the effective dose of the cholinergic receptor antagonist scopolamine (1 mg/kg) attenuated the scopolamine-induced memory impairment in the PA test in mice. Conclusion: Our experiments have shown that CB2 receptors participate in the modulation of memory-related responses, especially those in which cholinergic pathways are implicated.Keywords
Funding Information
- Medical University of Lublin (DS 23/22)
This publication has 72 references indexed in Scilit:
- Endocannabinoids in nervous system health and disease: the big picture in a nutshellPhilosophical Transactions of the Royal Society B: Biological Sciences, 2012
- Nicotine increases brain functional network efficiencyNeuroImage, 2012
- Chronic blockade of cannabinoid CB2receptors induces anxiolytic‐like actions associated with alterations in GABAAreceptorsBritish Journal of Pharmacology, 2011
- AM630 behaves as a protean ligand at the human cannabinoid CB2 receptorBritish Journal of Pharmacology, 2011
- Scopolamine prevents retrograde memory interference between two different learning tasksPhysiology & Behavior, 2011
- Inhibitory avoidance memory deficit induced by scopolamine: Interaction of cholinergic and glutamatergic systems in the ventral tegmental areaNeurobiology of Learning and Memory, 2010
- Scopolamine induced deficits in a battery of rat cognitive tests: comparisons of sensitivity and specificityBehavioural Pharmacology, 2009
- Nicotinic Acetylcholine Receptor Signalling: Roles in Alzheimer’s Disease and Amyloid NeuroprotectionPharmacological Reviews, 2009
- Cholinergic influence on memory stages: A study on scopolamine amnesic miceIndian Journal of Pharmacology, 2009
- The role of the cannabinoid system in nicotine addictionPharmacology Biochemistry and Behavior, 2005